Mirna Therapeutics is Austin’s Newest Public Company

Mirna Therapeutics became Austin’s newest publicly traded company last week. The biopharmaceutical company, which is developing therapies for the treatment of liver cancer, filed an amended S-1 Registration document with the U.S. Securities Exchange Commission to offer 6.2 million shares at $7 a share to raise $44 million during its initial public offering last Thursday. […]